Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Inventory (2017 - 2025)

Catheter Precision (VTAK) has disclosed Inventory for 9 consecutive years, with $34000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Inventory rose 6.25% to $34000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $34000.0, a 6.25% increase, with the full-year FY2024 number at $33000.0, down 25.0% from a year prior.
  • Inventory was $34000.0 for Q3 2025 at Catheter Precision, down from $48000.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $2.3 million in Q2 2021 to a low of $32000.0 in Q3 2024.
  • A 5-year average of $512187.5 and a median of $63500.0 in 2023 define the central range for Inventory.
  • Peak YoY movement for Inventory: tumbled 93.39% in 2023, then grew 12.7% in 2025.
  • Catheter Precision's Inventory stood at $986000.0 in 2021, then increased by 7.4% to $1.1 million in 2022, then plummeted by 95.85% to $44000.0 in 2023, then dropped by 25.0% to $33000.0 in 2024, then grew by 3.03% to $34000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Inventory are $34000.0 (Q3 2025), $48000.0 (Q2 2025), and $71000.0 (Q1 2025).